In August 2025, Aouns government committed to disarming all groups possessing heavy weapons, notably including Hezbollah, tasking the army with establishing a monopoly on weapons by the end of the year
Evoke and Evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimers disease
Medications are recommended to help alleviate symptoms and aid the healing process
NAD+ is the stronger choice for energy, cognition, and metabolic health
J Pharmacol Exp Ther 258:544550 [PubMed] [Google Scholar] Molinari P, Vezzi V, Sbraccia M, Gr C, Riitano D, Ambrosio C, Casella I, Costa T